Wilson Sonsini-Led Oric Pharmaceuticals Launches $75M IPO
Venture-backed oncology firm Oric Pharmaceuticals Inc. set a price range on Monday for an estimated $75 million initial public offering steered by Wilson Sonsini Goodrich & Rosati PC and underwriters counsel...To view the full article, register now.
Already a subscriber? Click here to view full article